Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity

By Koloszar S.   Pal Z.   Kereszturi A.   Vajda G.   Pal A.   Daru J.  

Climacteric, Vol. 15, Iss. 1, 2012-02 ,pp. : 93-94

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

By Berstein L.   Maximov S.   Gershfeld E.   Meshkova I.   Gamajunova V.   Tsyrlina E.   Larionov A.   Kovalevskij A.   Vasilyev D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 105, Iss. 2, 2002-11 ,pp. : 161-165

Elsevier

Access to resources Recommend Favorite

Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy

By Dian Darius   Schwenn Katja   Mylonas Ioannis   Janni Wolfgang   Jaenicke Fritz   Friese Klaus  

Archives of Gynecology and Obstetrics, Vol. 275, Iss. 6, 2007-06 ,pp. : 445-450

Springer Publishing Company

Access to resources Recommend Favorite

Impact of menopausal hormone. Replacement therapy on prognostic characteristics of breast cancer.

By Bonnier P.   Sakr R.   Bessenay F.   Lejeune C.   Charpin C.   Martin P.M.   Piana L.  

Gynecology Obstetrique & Fertilite, Vol. 28, Iss. 10, 2000-10 ,pp. : 745-753

Elsevier

Access to resources Recommend Favorite

Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients

By Pfeiler G.   Glatz C.   Köönigsberg R.   Geisendorfer T.   Fink-Retter A.   Kubista E.   Singer C. F.   Seifert M.  

Climacteric, Vol. 14, Iss. 3, 2011-06 ,pp. : 339-344

Informa Healthcare

Access to resources Recommend Favorite